The Future of Nigeria's Open Drug Markets

For decades, open drug markets have been the backbone of pharmaceutical distribution in Nigeria. Markets like Ogbogwu in Onitsha, Idumota in Lagos, Ariaria in Aba, and Sabon Gari in Kano have supplied medications to millions of Nigerians. But the era of unregulated open markets is coming to an end, and a new model is emerging to take its place.

The Problem with Open Markets

Nigeria's open drug markets emerged to fill a gap in pharmaceutical distribution. With limited formal supply chains, especially in rural and peri-urban areas, these markets became essential points of access for affordable medications. At their best, they democratised access to healthcare products for communities that formal pharmacies do not adequately serve.

However, the lack of regulation has created serious public health risks:

• Counterfeit drugs: The World Health Organisation estimates that up to 17% of drugs in low and middle-income countries are substandard or falsified. In Nigeria's open markets, this figure may be even higher.
• Improper storage: Many market shops lack temperature control, exposing heat-sensitive medications to conditions that degrade their potency. Drugs like insulin, certain antibiotics, and vaccines require specific storage conditions that open-air markets simply cannot provide.
• No traceability: Products move through multiple hands without documentation, making it nearly impossible to trace the source of a problematic batch or initiate effective recalls.
• Unqualified sellers: Many market traders lack pharmaceutical training, leading to incorrect dispensing advice and dangerous drug interactions.

Enter the Coordinated Wholesale Centre

NAFDAC's answer to these challenges is the Coordinated Wholesale Centre (CWC) model. CWCs are purpose-built facilities designed to provide a regulated environment for pharmaceutical wholesale trade. Key features include:

• Climate-controlled storage: All units within a CWC maintain pharmaceutical-grade storage conditions, protecting drug integrity from manufacture to retail.
• Entry requirements: Only registered pharmaceutical businesses with proper licensing can operate within a CWC. This ensures a baseline level of professionalism and accountability.
• Product verification: CWCs integrate NAFDAC's product verification systems, making it easier to confirm that products are genuine and registered.
• Digital record-keeping: Transactions are documented electronically, creating an auditable supply chain from manufacturer to wholesaler.

Where Are CWCs Being Built?

The Nigerian government, in partnership with NAFDAC and private developers, has identified several locations for CWC construction. The highest-priority sites correspond to existing major markets:

• Onitsha (Anambra): To absorb traders from Ogbogwu Market
• Lagos: To replace the pharmaceutical sections of Idumota Market
• Aba (Abia): For traders currently at Ariaria Market
• Kano: To serve the northern pharmaceutical distribution network based at Sabon Gari

What This Means for Drug Prices

A common concern is that moving to regulated facilities will increase drug prices. There is likely to be some upward pressure on costs due to higher rent and compliance expenses for traders. However, several factors could offset these increases:

• Reduced waste: Proper storage means fewer drugs expire prematurely or lose potency, reducing the effective cost of inventory.
• Lower counterfeiting: Removing fakes from the supply chain means consumers get drugs that actually work, reducing the need for repeated treatments.
• Economies of scale: CWCs can negotiate better logistics and infrastructure costs than individual market traders.

The Transition Challenge

The biggest challenge is managing the transition without disrupting access to medicines. Nigeria's open markets serve tens of millions of people, and any gap in supply could have serious public health consequences. The government must balance enforcement with realistic timelines for CWC completion and trader relocation.

For traders, the transition means adapting to new requirements. Understanding NAFDAC's registration process and drug importation regulations will be essential for anyone looking to continue in the pharmaceutical wholesale trade.

A Healthier Future

The move from open markets to CWCs represents the most significant reform in Nigeria's pharmaceutical distribution system in decades. While the transition will be disruptive, the long-term benefits — safer drugs, better storage, traceable supply chains, and improved public health outcomes — make it a necessary evolution.

We will continue to track these developments and provide practical guidance for traders and consumers navigating this changing landscape.

Disclaimer: This article is for informational purposes only and does not constitute legal or business advice. Consult with a licensed professional for guidance specific to your situation.